collaborate
collaborators
funding partners
affiliations
areas of collaboration

antigen discovery | development

adjuvant discovery | development | delivery

product development

drug discovery
Chembio's long and successful history with IDRI is testimony to their superior antigen discovery skills and global network of expertise. This, combined with our mutual commitment to global health and a complementary approach in our research and development collaborations together, has produced outstanding results.

Lawrence Siebert, CEO, Chembio Diagnostic Systems, Inc.
|  |
Product Development
We are uniquely positioned to transform candidate vaccines, diagnostics, and therapeutics into viable tools to control diseases of global importance. We have experience in translating late-stage research through the development pathway, and in leveraging commercial partnerships to get products on the market. We have expertise in protein and adjuvant process development, formulation, and manufacturing, as well as in regulatory affairs and clinical development.
Our Process Science group develops methods for producing recombinant proteins that can be transferred to large-scale manufacturing by partners. The group also applies up-to-date technologies in formulation and product characterization.
Our Adjuvant Formulation group produces a variety of adjuvants for use in vaccine research by us and our partners. Our group implements and transfers adjuvant processes to our in-house cGMP Production Facility for manufacture of clinical Phase 1/2 material. The manufacturing group encompasses production, formulation, fill/finish and quality functions.
Our Clinical Development team designs and implements clinical trials in support of our global mission. Candidates are either developed by our Preclinical Biology group or obtained from an external source through an institutional agreement. Through our extensive network of global connections, our Clinical Development team is able to prepare and launch clinical trials almost anywhere in the world.
We are interested in partners with promising product candidates that fit with our technical expertise and our mission.
|